New Issue: HSBC sells $1.20 million four-year Stars on S&P Biotechnology index

By Marisa Wong

Morgantown, W.Va., Dec. 1 – HSBC USA Inc. sold $1,195,000 of 0% Strategic Accelerated Redemption Securities due Nov. 29, 2021 linked to the S&P Biotechnology Select Industry index, according to an FWP filing with the Securities and Exchange Commission.

The notes will be called at par of $10 plus an annualized call premium of 12.81% if the index closes at or above its initial level on any of four annual review dates.

The payout at maturity will be par unless the index falls, in which case investors will be exposed to any losses.

BofA Merrill Lynch is the agent.

Issuer:	HSBC USA Inc.
Issue:	Strategic Accelerated Redemption Securities
Underlying index:	S&P Biotechnology Select Industry index
Amount:	$1,195,000
Maturity:	Nov. 29, 2021
Coupon:	0%
Price:	Par of $10
Payout at maturity:	Par unless the index falls, in which case investors will be exposed to any losses
Call:	At par plus an annualized call premium of 12.81% if the index closes at or above its initial level on any of four annual review dates
Initial level:	6,317.55
Pricing date:	Nov. 21
Settlement date:	Nov. 29
Agent:	BofA Merrill Lynch
Fees:	2%
Cusip:	40435H129

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.